UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized, comparative study of interferon β-1a treatment regimens in MS: The EVIDENCE Trial

Neurology, 2002-11, Vol.59 (10), p.1496-1506

2002

Volltextzugriff (PDF)

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability

Neurology, 1998-03, Vol.50 (3), p.701-708

1998

Volltextzugriff (PDF)

Developmental changes in chest wall compliance in infancy and early childhood

Journal of applied physiology (1985), 1995-01, Vol.78 (1), p.179-184

1995

Volltextzugriff (PDF)

Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment

Neurology, 2008-03, Vol.70 (13 Pt 2), p.1134-1140

2008

Volltextzugriff (PDF)

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

Multiple sclerosis, 2000-04, Vol.6 (4), p.255-266

2000

Volltextzugriff (PDF)

MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group

Neurology, 2002-10, Vol.59 (7), p.998-1005

CHAMPS Study Group

2002

Volltextzugriff (PDF)

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

The Lancet (British edition), 2005-08, Vol.366 (9485), p.579-582

2005

Volltextzugriff (PDF)

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial

Neurology, 1994-06, Vol.44 (6), p.1054-1054

1994

Volltextzugriff (PDF)

Bronchiolitis in infants

Current opinion in pediatrics, 2001-06, Vol.13 (3), p.256-260

Panitch, H B

2001

Volltextzugriff (PDF)

Interferons in multiple sclerosis : a review of the evidence

Drugs (New York, N.Y.), 1992-12, Vol.44 (6), p.946-962

PANITCH, H. S

1992

Volltextzugriff (PDF)

Intramedullary spinal cord abscess in a healthy woman

Neurology, 2007-04, Vol.68 (15), p.1230-1230

2007

Volltextzugriff (PDF)

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis

The New England journal of medicine, 2008-10, Vol.359 (17), p.1786-1801

2008

Volltextzugriff (PDF)

Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: A multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon β-1a for relapsing multiple sclerosis

Clinical therapeutics, 2007-09, Vol.29 (9), p.2031-2048

2007

Volltextzugriff (PDF)

Respiratory Care of the patient with duchenne muscular dystrophy: ATS Consensus statement

American journal of respiratory and critical care medicine, 2004-08, Vol.170 (4), p.456-465

2004

Volltextzugriff (PDF)

Exacerbations of multiple sclerosis in patients treated with gamma interferon

The Lancet (British edition), 1987-04, Vol.1 (8538), p.893-895

1987

Volltextzugriff (PDF)

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

Neurology, 2002-11, Vol.59 (10), p.1496

2002

Volltextzugriff (PDF)

Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study

Neurology, 2004-11, Vol.63 (10), p.1788-1795

2004

Volltextzugriff (PDF)

A70 PULMONARY REHABILITATION IN LUNG TRANSPLANTATION AND THE ACUTE SETTING: View Of Directors Of Home Ventilation Programs On Decisions Around Long-Term Ventilation

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration

Neurology, 1996-06, Vol.46 (6), p.1639-1643

1996

Volltextzugriff (PDF)

Chest wall compliance in infants and children with neuromuscular disease

American journal of respiratory and critical care medicine, 1996-10, Vol.154 (4 Pt 1), p.1045-1048

1996

Volltextzugriff (PDF)

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

Lancet neurology, 2008-10, Vol.7 (10), p.903-914

2008

Volltextzugriff (PDF)

The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study

Multiple sclerosis, 1995-11, Vol.1 (3), p.165-169

1995

Volltextzugriff (PDF)

D25 NEONATAL AND CONGENITAL LUNG DISEASES: Outcomes In Neonates With Bronchopulmonary Dysplasia And Tracheobronchomalacia

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

B52 NEONATAL LUNG DISEASE: FROM BENCH TO BABIES: Bethanechol Improves Respiratory Symptoms In Young Children With Tracheomalacia

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial

Neurology, 1996-12, Vol.47 (6), p.1457-1462

1996

Volltextzugriff (PDF)

1 – 25 von 196

Suche als RSS-Feed

Aktive Filter

ThemaNeurosciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(109)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Randomized, comparative study of interferon β-1a treatment regimens in MS: The EVIDENCE Trial

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability

Developmental changes in chest wall compliance in infancy and early childhood

Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial

Bronchiolitis in infants

Interferons in multiple sclerosis : a review of the evidence

Intramedullary spinal cord abscess in a healthy woman

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis

Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: A multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon β-1a for relapsing multiple sclerosis

Respiratory Care of the patient with duchenne muscular dystrophy: ATS Consensus statement

Exacerbations of multiple sclerosis in patients treated with gamma interferon

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study

A70 PULMONARY REHABILITATION IN LUNG TRANSPLANTATION AND THE ACUTE SETTING: View Of Directors Of Home Ventilation Programs On Decisions Around Long-Term Ventilation

Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration

Chest wall compliance in infants and children with neuromuscular disease

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study

D25 NEONATAL AND CONGENITAL LUNG DISEASES: Outcomes In Neonates With Bronchopulmonary Dysplasia And Tracheobronchomalacia

B52 NEONATAL LUNG DISEASE: FROM BENCH TO BABIES: Bethanechol Improves Respiratory Symptoms In Young Children With Tracheomalacia

Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial

Aktive Filter

Suchergebnisse filtern